Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
08/2008
08/20/2008EP1957462A2 Novel 2-amino-heterocycles udeful in the treatment of abeta-related pathologies
08/20/2008EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1375489B1 Medicinal composition containing 1,3-thiazine derivative
08/20/2008CN101248074A Xanthine oxidase inhibitor
08/20/2008CN101247807A Thiazole compounds and methods of use
08/19/2008US7414070 Indol-7-YL sulfonamide derivatives, their preparation and their use in pharmaceutical compositions
08/19/2008US7414066 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders
08/19/2008CA2432799C Pyrazole compounds useful as protein kinase inhibitors
08/19/2008CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives
08/14/2008US20080194547 6-{[(3-{2-[6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-azabicyclo[3.1.0]hex-6-yl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
08/13/2008EP1954696A2 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
08/13/2008EP1954128A2 Diphenylmethane derivatives as inhibitors of leukotriene biosynthesis
08/13/2008EP1495030B1 Non-steroidal progesterone receptor modulators
08/13/2008EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function
08/13/2008EP1452528B1 Xanthine oxidase inhibitors
08/13/2008CN101243068A Compounds for the treatment of multi-drug resistant bacterial infections
08/12/2008US7410933 Substituted thiene-3-ylsulphonylamino(thio)carbonyl-triazolin(thi)ones
08/12/2008CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
08/07/2008WO2008092665A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008CA2675466A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/06/2008EP1953153A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/06/2008EP1951731A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/06/2008CN101237892A Method of conjugating aminothiol containing molecules to vehicles
08/06/2008CN100408573C Pyrazole compounds useful as protein kinase inhibitors
08/05/2008US7408062 Rigidized trimethine cyanine dyes
08/05/2008US7407977 N-(8H-Indeno[1,2-d]thiazol-2-yl)-benzamide; antidiabetic agent; adenosine 2B receptor antagonists; antidiabetic agent; diabetic retinopathy, asthma and diarrhea; antidepressant, hypotensive agent, Parkinson's disease
08/05/2008CA2388476C Bicyclic imidazo-5-yl-amine derivatives
07/2008
07/31/2008WO2008089892A1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals
07/31/2008WO2008005456A3 Fused heterocyclic inhibitors of d-amino acid oxidase
07/31/2008US20080182840 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
07/30/2008EP1948667A2 Thiazolo[4,5-c]pyridine derivatives as mglu5 receptor antagonists
07/30/2008CN101233132A Compounds for modulating TRPV3 function
07/30/2008CN100406461C Sulphur containing heterocyclic and naphthalimides compound and use thereof
07/30/2008CN100406454C Pyrazole compounds useful as protein kinase inhibitors.
07/29/2008US7405302 5-lipoxygenase-activating protein (FLAP) inhibitors
07/29/2008US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
07/29/2008US7405212 Helix mimetics and composition and methods related thereto
07/29/2008US7405041 Methods for regulating transcription by targeting quadruplex DNA
07/29/2008CA2432222C Pyrazole compounds useful as protein kinase inhibitors
07/29/2008CA2432132C Pyrazole compounds useful as protein kinase inhibitors
07/24/2008WO2008065626A3 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors
07/24/2008WO2008062463A3 Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-l,2-thiazine-6-sulfonamide-l,l-dioxide
07/24/2008WO2007120638A3 Methods and compositions for modulating glycosylation
07/24/2008US20080176893 Formulation of a Thienopyridine Platelet Aggregation Inhibitor
07/24/2008US20080176835 Prenyl Transferase Inhibitors
07/23/2008EP1945648A1 Derivatives of 4,6-disubstituted 1,2,4-triazolo-1,3,4-thiadiazole, a process and uses thereof
07/23/2008CN100404540C Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting prot ein kinases
07/22/2008US7402593 (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazo[4,5-b]pyridine; proton pump inhibitor (PPI) to treat gastro-oesophageal reflux, digestive bleeding and dyspepsia; enantiomer; long duration of action; longer half-life in plasma; oxidation of sulfide followed by salt formation
07/22/2008US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants
07/22/2008US7402421 Recombinant methods and materials for producing epothilone and epothilone derivatives
07/22/2008CA2436942C Method of manufacturing substance gm-95
07/17/2008WO2008084873A1 Oxime derivative
07/17/2008WO2008084872A1 Hydrazone derivative
07/17/2008US20080171692 Substituted amides
07/16/2008EP1943222A1 Antibacterial active 5-chinolin derivative
07/16/2008EP1466527B1 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same
07/16/2008CN101220045A Preparation and application of phenanthrene ring conjugation, center modification expansion porphyrin derivant
07/16/2008CN101220044A Telomerase inhibitor, preparation method and application thereof
07/16/2008CN101220043A Benzothiazolo [3, 2,-a]-miazine derivant and uses thereof
07/16/2008CN101220027A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
07/16/2008CN100402032C Tetrahydroquinoline analogues as muscarinic agonists
07/15/2008US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
07/15/2008US7399768 1-methyl-3 beta -hydroxymethyl-6-methoxy-1,2,3,4,4a alpha ,5,10, 10a beta -octahydrobenzo[q]quinoline; decrease on the intraocular pressure; glaucoma and myopia; excellent tolerability, and a long duration of action
07/15/2008US7399765 Substituted diazabicycloalkane derivatives
07/10/2008WO2008082484A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/10/2008WO2008081399A2 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
07/10/2008WO2008048991A3 Organic compounds
07/10/2008US20080167475 Intermediates of 2-substituted carbapenem derivatives and process for production thereof
07/10/2008CA2673506A1 Antibacterial compounds and processes for its production
07/10/2008CA2673249A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/10/2008CA2669821A1 2-aza-bicyclo[3.1.0]hexane derivatives
07/09/2008EP1940850A2 Fused tetracyclic mglur1 antagonists as therapeutic agents
07/09/2008EP1940849A1 Isothiazolopyridin-3-ylenamines for combating animal pests
07/09/2008EP1940296A2 Chemical compounds
07/09/2008CN101218237A Oxime derivative and preparations thereof
07/09/2008CN101218236A 2-heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
07/09/2008CN100400519C N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
07/08/2008US7396932 Fusing a N-phenyl-C-leaving group-C-carbonyl- or oxycarbonylhydrazide with a 1-(p-nitrophhenyl)-3-halo-tetrahydro-2-piperidone; subsequent reactions include reduction and amidation of the nitro group and amidation of carbonyl or ester group; final products include factor Xa inhibitors
07/08/2008CA2432131C Pyrazole compounds useful as protein kinase inhibitors
07/03/2008WO2008078725A1 Thiazepine derivative
07/03/2008WO2008078674A1 Glucokinase-activating substance
07/03/2008US20080161557 Synthesis of 2-Methyl-4-(4-Methyl-1-Piperazinly)-10H-Thieno(2,3-B) (1,5) Benzodiazepine and Salts Thereof
07/03/2008US20080161426 p53 Inhibitors and Therapeutic Use of the Same
07/03/2008US20080161341 Novel imidazothiazoles and imidazoxazoles
07/03/2008US20080161289 6-Cyclobutyl-2-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-4H-[1,3]thiazolo[4,5-d]azepine; neurological and psychiatric disorders
07/03/2008US20080161288 e.g. 7-hydroxy-6-{(1R*)-[3-(4-hydroxyphenyl)-1-methylpropyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; beta-2 adrenoceptor agonist; as a teed additive for a livestock animal as poultry and birds; veterinary medicine
07/03/2008US20080159982 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients
07/03/2008CA2672088A1 Glucokinase activator
07/02/2008EP1939205A1 Tricyclic compound
07/02/2008EP1496838A4 Substituted amides
07/01/2008US7393954 Process for the production of pentostatin aglycone and pentostatin
07/01/2008US7393873 Arylsulfonamide derivatives
07/01/2008US7393867 6-phenylsulfanyl-4H-pyrrolo[2,3-d]thiazole-5-carboxylic acid amide; mood disorders; sleep disorders; major depressive disorder; circadian rhythm sleep disorders; jet lag syndrome; bipolar disorders; reaction with diaryldisulfide or diheteroaryldisulfides to give desired compounds
07/01/2008US7393866 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents
07/01/2008US7393854 Respiratory system disorders; asthma
07/01/2008US7393843 amyloid precursor protein and gamma -secretase inhibitor; 3,4,6,7,8,9-Hexahydro-2-methyl-3-oxo-2H-naphtho[2,3-e]-1,2-thiazine-4-carboxanilide 1,1-dioxide; neurodegenerative disease: Alzheimer's disease, amyloid plaque, Parkinson's disease, Down's syndrome, hemorrhage, arteriosclerosis
06/2008
06/26/2008WO2008076883A2 Triazine derivatives and their therapeutical applications
06/26/2008WO2008076562A1 5- [4- (azetidin-3-yl0xy) -phenyl] -2-phenyl-5h-thiaz0l0 [5,4-c] pyridin-4-0ne derivatives and their use as mch receptor antagonists
06/26/2008WO2008075155A2 Carbonic anhydrase inhibitors derivatives
06/26/2008WO2008075103A1 Antiviral indoles
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 152